Collections

Business on the Front Lines

News and perspectives from corporations working to directly impact the COVID-19 public health crisis. Content from this collection may include updates from medical supply or pharmaceutical companies, businesses that have pivoted their production to support the medical response to COVID-19 or hospitals that are navigating many secondary impacts of the pandemic (both economic and human).

Fast action creates 10,000 medical face shields in 23 days

Pivot toward protection, Fast action creates 10,000 medical face shields in 23 days

By: Raytheon
Source: Raytheon
Date of Publication: April 30th, 2020
On March 30, Raytheon Technologies CEO Greg Hayes made a promise to the nation. At the White House, he announced the company would deploy 3D printers and other technology to produce 10,000 medical face shields. That goal was reached in 23 days, and now Raytheon Technologies is aimed at more than doubling that production while the pandemic rages.
Facebook Details New Data for Good Initiatives Related to Covid-19_Adweek

Facebook Details New Data for Good Initiatives Related to Covid-19

By: David Cohen
Source: Adweek
Date of Publication: June 3rd, 2020
Facebook released new visualizations and datasets that are part of its Data for Good initiative, as well as a new survey related to Covid-19.
AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works

By: Matthew Herper
Source: Stat News
Date of Publication: June 4th, 2020
The drug giant AstraZeneca said Thursday that it has found partners to manufacture and distribute 2 billion doses of the experimental Covid-19 vaccine created by Oxford University, inking a series of deals with non-government organizations and another manufacturer.
Coronavirus: AstraZeneca to begin making potential vaccine

Coronavirus: AstraZeneca to begin making potential vaccine

Source: BBC News
Date of Publication: June 5th, 2020
Drug company AstraZeneca is to start producing a potential vaccine for coronavirus, its boss has told the BBC.
May’s Unemployment Rate Could Exceed 20% And Even Hit The Great Depression’s 25%

May’s Unemployment Rate Could Exceed 20% And Even Hit The Great Depression’s 25%

By: Chuck Jones
Source: Forbes
Date of Publication: June 4th, 2020
On Friday the Department of Labor will release May’s employment report, and expectations are for an additional 9 million people to have lost their jobs. Depending on how many stopped looking for work, and are therefore not counted as unemployed, 9 million added to the jobless roles would increase the unemployment rate to just over 20%.
Unemployment in U.S. Unexpectedly Fell in May: Live Updates

Unemployment in U.S. Unexpectedly Fell in May: Live Updates

Source: New York Times
Date of Publication: June 5th, 2020
Hiring rebounded in May, defying expectations, with 2.5 million jobs added, the Labor Department said.
Nike Covid Leadership

How Nike is striking the right tone with its response to Covid-19

By: Nikki Gilliland
Source: Ecoconsultancy
Date of Publication: April 15th, 2020
An article praising Nike's response to the covid-19 crisis. Uses brand to evoke emotional responses that praise social distancing efforts
Movie theater chain AMC warns it may not survive the pandemic

Movie theater chain AMC warns it may not survive the pandemic

By: The Associated Press
Source: Fortune
Date of Publication: June 3rd, 2020
Movie theater chain AMC warned Wednesday that it may not survive the coronavirus pandemic, which has shuttered its theaters and led film studios to explore releasing more movies directly to viewers over the internet.
A COVID-19 vaccine has passed its first human trial. But is it the frontrunner?

A COVID-19 vaccine has passed its first human trial. But is it the frontrunner?

By: Nsikan Akpan
Source: National Geographic
Date of Publication: May 29th, 2020
Moderna Therapeutics has just entered phase two of its clinical trials. Here's how mRNA vaccines work and what the latest developments mean.
Eli Lilly starts human study of a potential coronavirus treatment

Eli Lilly starts human study of a potential coronavirus treatment

By: Reuters
Source: CNBC
Date of Publication: June 1st, 2020
Eli Lilly said on Monday it had started an early-stage trial to test its potential treatment for Covid-19, in the world’s first study of an antibody treatment against the disease.

Browse Collections

  • The Changing Nature of Work COVID-19

    The Changing Nature of Work

    From virtual offices to essential workers, explore how companies are adapting to changes in the way we work.
    Read More
  • Business on the Front Lines COVID-19

    Business on the Front Lines

    News and perspectives from corporations rising to the challenge of the COVID-19 public health crisis.
    Read More
  • Leading in a Crisis COVID-19.

    Leading in a Crisis

    Uncertainty can be disorienting and disruptive. Learn from business leaders about what it’s like to navigate their organizations and people through a global pandemic.
    Read More
  • Service and Community COVID-19

    Service and Community

    We’re in this together. Discover ways corporations are serving their communities and pivoting to become essential services.
    Read More